Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denardo

Showing results (191-200 of 274) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Requirements for a treatment planning system for radioimmunotherapyG L DeNardo, A Raventos, H H Hines, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Metabolite production in patients with lymphoma after radiometal-labeled antibody administrationG L DeNardo, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibodyH B Breitz, J S Durham, D R Fisher, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancerS J DeNardo, S V Deshpande, M K Moi, et al.
Cancer Research|April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in miceG P Adams, S J DeNardo, S V Deshpande, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenograftsR T O'Donnell, S J DeNardo, L A Miers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapySally J DeNardo, Gerald L DeNardo, Laird A Miers, et al.
Biochemical and Molecular Medicine|April 1, 1997
Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growthG Morris, S J DeNardo, G L DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored miceS V Deshpande, S J DeNardo, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in miceSally J DeNardo, Gerald L DeNardo, Arutselvan Natarajan, et al.
Pageof 28

Showing results (191-200 of 274) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Requirements for a treatment planning system for radioimmunotherapyG L DeNardo, A Raventos, H H Hines, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Metabolite production in patients with lymphoma after radiometal-labeled antibody administrationG L DeNardo, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibodyH B Breitz, J S Durham, D R Fisher, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancerS J DeNardo, S V Deshpande, M K Moi, et al.
Cancer Research|April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in miceG P Adams, S J DeNardo, S V Deshpande, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenograftsR T O'Donnell, S J DeNardo, L A Miers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapySally J DeNardo, Gerald L DeNardo, Laird A Miers, et al.
Biochemical and Molecular Medicine|April 1, 1997
Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growthG Morris, S J DeNardo, G L DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored miceS V Deshpande, S J DeNardo, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in miceSally J DeNardo, Gerald L DeNardo, Arutselvan Natarajan, et al.
Pageof 28